<!DOCTYPE html>
<html class="no-js">

<head>
	<meta charset="utf-8">
	<meta http-equiv="X-UA-Compatible" content="IE=edge">
	<title>Sarcomas</title>
	<meta name="viewport" content="width=device-width, initial-scale=1">
	<meta name="description" content="Sarcomas" />
	<meta name="keywords" content="oncologia, medicina" />
	<meta name="author" content="e-oncologia" />

	<link rel="shortcut icon" type="image/png" href="images/logopeque.png" />

	<link href="https://fonts.googleapis.com/css?family=Open+Sans&display=swap" rel="stylesheet">
	<link href='https://fonts.googleapis.com/css?family=Montserrat:400,700' rel='stylesheet' type='text/css'>

	<link rel="stylesheet" href="css/animate.css">
	<link rel="stylesheet" href="css/icomoon.css">
	<link rel="stylesheet" href="css/bootstrap.css">
	<link rel="stylesheet" href="css/owl.carousel.min.css">
	<link rel="stylesheet" href="css/owl.theme.default.min.css">
	<link rel="stylesheet" href="css/style.css">
	<script src="js/modernizr-2.6.2.min.js"></script>

</head>

<body>

	<div id="ico-page">
		<a href="#" class="js-ico-nav-toggle ico-nav-toggle"><i></i></a>

		<aside id="ico-aside" role="complementary" class="border js-fullheight" style="background-image: url(images/BGoscuro.jpg);">
			<p><br></p>
			<h2 id="ico-logo"><a href="index.html"><img src="images/logo.png" height="80"></a></h2>
			<nav id="ico-main-menu" role="navigation">
				<ul>
					<li><a href="m1u0.html"><span class="bgdestacado2">PRESENTACIÓN</span></a></li>
					<br>
					<li><a href="m1u1.html"><span class="bgdestacado2">MÓDULO 1</span><br>SARCOMAS DE PARTES BLANDAS</a></li>
					<br>
					<li><a href="m2u1.html"><span class="bgdestacado2">MÓDULO 2</span><br>ESTROMA GASTROINTESTINAL</a></li>
				
					<br>
					<li><a href="m3u1.html"><span class="bgdestacado2">MÓDULO 3</span><br>TUMORES ÓSEOS</a></li>
					<br>
					<li><a href="m4u1.html"><span class="bgdestacado2">BIBLIOGRAFÍA</a></li>
					<ol>
						<li><a href="#1">Sarcomas de partes blandas</a></li>
						<li><a href="#2">Osteosarcoma</a></li>
						<li><a href="#3">Sarcoma de Ewing</a></li>
					</ol>
				</ul>
			</nav>
		</aside>

		<div id="ico-main">

			<div class="ico-cabeceraVERDE">
					<div class="ico-narrow-content animate-box">
						<h4 class="text-center blanco">Bibliografía</h4>
						<img src="images/ICONObiblio.png" alt="" class="img-responsive centrada">
					</div>
				</div>


		
			<div class="ico-narrow-content">
				<div class="row animate-box" data-animate-effect="fadeInLeft">
					<div class="col-md-12">
						<h3 id="1">Sarcomas de partes blandas</h3>
						<p class="marcoOSCURO"><span class="verde">Casali PG, Abecassis N, Bauer S, Biagini R, Bielack S, et al.</span> Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Annals of Oncology, Volume 29, iv51 - iv67.</p>
						<p class="marcoOSCURO"><span class="verde">Xavier García del Muro, Javier Martín, Joan Maurel, Ricardo Cubedo, Silvia Bagué, et al, en representación del Grupo Español de Investigación en Sarcomas (GEIS).</span> Guía de práctica clínica en los sarcomas de partes blandas.</p>
						<p class="marcoOSCURO"><span class="verde">Lugowska, Jean-Yves Blay, Hans Gelderblom et al.</span> Sarcoma & GIST plus cancer of unknown primary site: Essentials for clinicians. OmcolgyPRO ESMO 2020.</p>
						<p class="marcoOSCURO">WHO Classification of Tumours Editorial Board. Soft Tissue and Bone Tumours. WHO Classification of Tumours, 5th Edition, Volume 3ISBN-13 (Print Book) 978-92-832-4502-5 Mayo 2020.</p>
						<p class="marcoOSCURO"><span class="verde">Vicens Artigas, José Cervera, Juan R. Delgado, Xavier García del Muro, Manuel García de Polavieja, et al. Coordinador: Andrés Poveda, en representación del Grupo Español de Investigación en Sarcomas (GEIS).</span> Guía de práctica clínica en los tumors estromales gastrointestinales (GIST) Actualización 2010.</p>
						<p class="marcoOSCURO"><span class="verde">Poveda, V. Martinez, C. Serrano, I. Sevilla, M. J. Lecumberri, et al.</span> SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016) Clin Transl Oncol (2016) 18:1221–1228 DOI 10.1007/s12094-016-1579-9.</p>
						<p class="marcoOSCURO"><span class="verde">Demetri GD, Reichardt P, Kang YK, Blay JY, Rutkowski P, Gelderblom H, Hohenberger P, Leahy M, von Mehren M, Joensuu H, Badalamenti G, Blackstein M, Le Cesne A, Schöffski P, Maki RG, Bauer S, Nguyen BB, Xu J, Nishida T, Chung J, Kappeler C, Kuss I, Laurent D, Casali PG; GRID study investigators. </span> Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet. 2013 Jan 26;381(9863):295-302. doi: 10.1016/S0140-6736(12)61857-1. Epub 2012 Nov 22. PMID: 23177515; PMCID: PMC3819942.</p>
						<p class="marcoOSCURO"><span class="verde">Blay JY, Serrano C, Heinrich MC, Zalcberg J, Bauer S, Gelderblom H, Schöffski P, Jones RL, Attia S, D'Amato G, Chi P, Reichardt P, Meade J, Shi K, Ruiz-Soto R, George S, von Mehren M.</span> . Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Oncol. 2020 Jul;21(7):923-934. doi: 10.1016/S1470-2045(20)30168-6. Epub 2020 Jun 5. Erratum in: Lancet Oncol. 2020 Jul;21(7):e341. PMID: 32511981.</p>
						<p class="marcoOSCURO"><span class="verde">Heinrich MC, Jones RL, von Mehren M, Schöffski P, Serrano C, Kang YK, Cassier PA, Mir O, Eskens F, Tap WD, Rutkowski P, Chawla SP, Trent J, Tugnait M, Evans EK, Lauz T, Zhou T, Roche M, Wolf BB, Bauer S, George S. </span> Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial. Lancet Oncol. 2020 Jul;21(7):935-946. doi: 10.1016/S1470-2045(20)30269-2. Erratum in: Lancet Oncol. 2020 Sep;21(9):e418. PMID: 32615108.</p>


					<br>

						<h3 id="2">Osteosarcoma</h3>
						<p class="marcoOSCURO"><span class="verde">Andres Redondo, Alejandro Braña, Silvia Bagué, Antonio López Pousa, et al, en representación del Grupo Español de Investigación en Sarcomas (GEIS). </span> Osteosarcoma del adulto. Guía de Buena práctica clínica.</p>
						<p class="marcoOSCURO"><span class="verde">Andrés Redondo, Silvia Bagué, Daniel Bernabeu, Eduardo Ortiz-Cruz, Claudia Valverde, et al.</span> Malignant bone tumors (other than Ewing’s): clinical practice guidelines for diagnosis, treatment and follow-up by Spanish Group for Research on Sarcomas (GEIS). Cancer Chemother Pharmacol DOI 10.1007/s00280-017-3436-0.</p>
						<p class="marcoOSCURO"><span class="verde">Hawkins MM, Wilson LM, Burton HS et al.</span> Radiotherapy, alkilating agents and risk of bone cancer after childhood cancer. J Natl Cancer Inst 1996; 88:270-276.</p>
						<p class="marcoOSCURO"><span class="verde">Hansen MF, Koufos A, Gallie BL, et al.</span> Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci USA 1985; 82: 6216-6222.</p>
						<p class="marcoOSCURO"><span class="verde">Toguchida J, Y.T., Dayton SH, et al.</span> Prevalence and spectrum of germline mutations of p53 gene among patients with sarcoma. N Engl J Med, 1992; 326: 1301-1308.</p>
						<p class="marcoOSCURO"><span class="verde">Wang LL, Gannavarapu A, Kozinetz CA, et al. </span> Association between osteosarcoma and deleterious mutations in the RECQL4 gene in Rothmund-Thompson syndome. J Natl Cancer Inst 2003; 95:669-674.</p>
						<p class="marcoOSCURO"><span class="verde">Kaste SC, P.C., Cain AM, et al.</span> Metastases detected at time of diagnoses of primary pediatric extremity osteosarcoma at diagnostic: imaging features. Cancer, 1999(89): p. 1602-1608.</p>
						<p class="marcoOSCURO"><span class="verde">Link MP, G.A., Miser AW, et al.</span> The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med, 1986. 314: p. 1600-1606.</p>
						<p class="marcoOSCURO"><span class="verde">Raymond AK, A.A., Knuutila S, et al.</span> WHO Classification of Tumors: Pathology and Genetics of Tumours of soft tissune and bone. Lyon, France. IARC Press, 2002: p. 264-270.</p>
						<p class="marcoOSCURO"><span class="verde">Michael J.Klein.</span> G.P.S., Osteosarcoma: Anatomic and Histologic Variants. Am J Clin Pathol, 2006. 125: p. 555-581.</p>
						<p class="marcoOSCURO"><span class="verde">Nakajima H, S.F., Bond JR, et al.</span> Small cell osteosarcoma of bone: review of 72 cases. Cancer, 1997. 79: p. 2095-9106.</p>
						<p class="marcoOSCURO"><span class="verde">Enneking WF.</span> A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop, 1980. 153: p. 106-120.</p>
						<p class="marcoOSCURO"><span class="verde">Eilber F, G.A., Eckardt J, et al.</span> Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol, 1987(5): p. 21-26.</p>
						<p class="marcoOSCURO"><span class="verde">Bramwell VH, B.M., Sneath R, et al.</span> A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup. J Clin Oncol, 1992(10): p. 1579-91.</p>
						<p class="marcoOSCURO"><span class="verde">Goorin AM, H.M., Bernstein M, et al.</span> Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a Pediatric Oncology Group trial. J Clin Oncol, 2002(20): p. 426-433.</p>
						<p class="marcoOSCURO"><span class="verde">Harris MB, G.P., Goorin AM et al.</span> Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group study. J Clin Oncol, 1998(16): p. 3641-3648.</p>
						<p class="marcoOSCURO"><span class="verde">Rosen G, M.R., Caparros B, et al.</span> Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer, 1979(43): p. 2163-2177.</p>
						<p class="marcoOSCURO"><span class="verde">Rosen G, Caparros B, Huvos AG, et al.</span> Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982; 49: 1221-30.</p>
						<p class="marcoOSCURO"><span class="verde">Goorin AM, S.D., Devidas M, et al.</span> Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group study POG-8651. J Clin Oncol, 2003(21): p. 1574-1580.</p>
						<p class="marcoOSCURO"><span class="verde">Souhami RL, C.A., Van der Eijken JW, et al.</span> Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet, 1997. 350: p. 911-917.</p>
						<p class="marcoOSCURO"><span class="verde">Bacci G, B.F., Longhi A, et al.</span> Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor. Cancer, 2003. 97: p. 3068-3075.</p>
						<p class="marcoOSCURO"><span class="verde">Stefan S.Bielack, B.K.-B., Günter Delling, et al.</span> Prognostic Factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1702 patients treated on neoadjuvant cooperative osteosarcoma study Group Protocols. J Clin Oncol, 2002. 3(1): p. 776-790.</p>
						<p class="marcoOSCURO">PDQ Pediatric Treatment Editorial Board. Osteosarcoma and Undifferentiated Pleomorphic Sarcoma of Bone Treatment (PDQ®): Health Professional Version. 2020 Oct 7. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. PMID: 26389179.</p>
						<p class="marcoOSCURO"><span class="verde">Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, et al.</span> Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. Lancet Oncol. 2016 Oct;17(10):1396-1408. doi: 10.1016/S1470-2045(16)30214-5. Epub 2016 Aug 25. PMID: 27569442; PMCID: PMC5052459.</p>


						<br>

					


						<h3 id="3">Sarcoma de Ewing</h3>
						<p class="marcoOSCURO"><span class="verde">Rosen G, W.N., Tan C, et al.</span> Proceedings: disease-free survival in childrens Ewing's sarcoma treated with radiation therapy and adjuvant four-drug sequential chemotherapy. Cancer, 1974. 33: p. 384-393.</p>
						<p class="marcoOSCURO"><span class="verde">Nesbit ME Jr, G.E., Burgert EO, et al.</span> Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup Study. J Clin Oncol, 1990. 8: p. 1664-1674.</p>
						<p class="marcoOSCURO"><span class="verde">Craft AW, C.S., Bullimore JA, et al.</span> Long-term results from the first UKCCSG Ewing's Tumor Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party. Eur J Cancer, 1997. 33: p. 1061-1069.</p>
						<p class="marcoOSCURO"><span class="verde">Craft AW, C.S., Malcolm A, et al.</span> Ifosfamide-containing chemotherapy in Ewing's sarcoma: the Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study. J Clin Oncol, 1998. 16: p. 3628-3633.</p>
						<p class="marcoOSCURO"><span class="verde">Grier HE, K.M., Tarbell NJ, et al.</span> Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med, 2003. 348: p. 694-701.</p>
						<p class="marcoOSCURO"><span class="verde">Schuck A, A.S., Pauluseen M, et al.</span> Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86 and EICESS 92 trials. Int J Radiat Oncol Biol Phys, 2003. 55: p. 168-177.</p>
						<p class="marcoOSCURO"><span class="verde">Trang H, M.P., Wexler L, et al.</span> Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era. Int J Radiat Oncol Biol Phys, 2006. 64(2): p. 544-550.</p>
						<p class="marcoOSCURO"><span class="verde">Dunst J, J.H., Sauers R, et al.</span> Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial. Int J Radiat Oncol Biol Phys, 1995. 32: p. 919-930.</p>
						<p class="marcoOSCURO"><span class="verde">Cotterill SJ, A.S., Paulussen M, et al.</span> Prognostic factors in Ewing's Tumor of Bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol, 2000. 18(17): p. 3108-3114.</p>
						<p class="marcoOSCURO"><span class="verde">Bovée JV, C.-J.A., Taminiau AH, et al.</span> Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. The Lancet, 2005. 6: p. 599-607.</p>
						<p class="marcoOSCURO"><span class="verde">Rozeman LB, C.-J.A., Hogendoorn PC, et al.</span> Pathology of primary malignant bone and cartilage tumours. International Orthopaedics (SICOT), 2006. 30: p. 437-444.</p>
						<p class="marcoOSCURO"><span class="verde">Sbaraglia M, Righi A, Gambarotti M, Dei Tos AP.</span> Ewing sarcoma and Ewing-like tumors. Virchows Arch. 2020 Jan;476(1):109-119. doi: 10.1007/s00428-019-02720-8. Epub 2019 Dec 4. PMID: 31802230.</p>
						<p class="marcoOSCURO">PDQ Pediatric Treatment Editorial Board. Ewing Sarcoma Treatment (PDQ®): Health Professional Version. 2020 Aug 11. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. PMID: 26389480.</p>
						<p class="marcoOSCURO"><span class="verde">Whelan J, Le Deley MC, Dirksen U, Le Teuff G, Brennan B, et al.</span> Euro-E.W.I.N.G.99 and EWING-2008 Investigators. High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008. J Clin Oncol. 2018 Sep 6;36(31):JCO2018782516. doi: 10.1200/JCO.2018.78.2516. Epub ahead of print. PMID: 30188789; PMCID: PMC6209090.</p>
						<p class="marcoOSCURO"><span class="verde">Dirksen U, Brennan B, Le Deley MC, Cozic N, van den Berg H, et al.</span> Euro-E.W.I.N.G. 99 and Ewing 2008 Investigators. High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008. J Clin Oncol. 2019 Dec 1;37(34):3192-3202. doi: 10.1200/JCO.19.00915. Epub 2019 Sep 25. PMID: 31553693; PMCID: PMC6881099.</p>
						<p class="marcoOSCURO"><span class="verde">Martin G. McCabe, Veronica Moroz, Maria Khan, Uta Dirksen, et al, and Euro Ewing Consortium.</span> Results of the first interim assessment of rEECur, an international randomized controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma. Journal of Clinical Oncology 2019 37:15_suppl, 11007-11007.</p>
						<p class="marcoOSCURO"><span class="verde">Martin G. McCabe, Laura Kirton, Maria Khan, Nicola Fenwick, Uta Dirksen, et al.</span> Results of the second interim assessment of rEECur, an international randomized controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma (RR-ES). Journal of Clinical Oncology 2020 38:15_suppl, 11502-11502.</p>
						






					
					</div>
				</div>
			</div>
			
			

			
		




	
		

			

		



		


		
		

			

			

			

		
					

		

		

		









			<div class="ico-cabecera">
				<div class="ico-narrow-content">
					<div class="pager">
						<br>
					</div>
				</div>
			</div>










		</div>
	</div>

	<!-- jQuery -->
	<script src="js/jquery.min.js"></script>
	<!-- jQuery Easing -->
	<script src="js/jquery.easing.1.3.js"></script>
	<!-- Bootstrap -->
	<script src="js/bootstrap.min.js"></script>
	<!-- Carousel -->
	<script src="js/owl.carousel.min.js"></script>
	<!-- Stellar -->
	<script src="js/jquery.stellar.min.js"></script>
	<!-- Waypoints -->
	<script src="js/jquery.waypoints.min.js"></script>
	<!-- Counters -->
	<script src="js/jquery.countTo.js"></script>
	<!-- MAIN JS -->
	<script src="js/main.js"></script>
	<!-- partial -->
	<script src='https://cdnjs.cloudflare.com/ajax/libs/vue/2.5.13/vue.min.js'></script>
	<script src="js/scriptdiagram.js"></script>

</body>

</html>
